Raia Drogasil (BSP:RADL3) ROE % Adjusted to Book Value: 1.55% (As of Mar. 2026)


BSP:RADL3 Raia Drogasil SA BSP:RADL3
91 GF Score
Price R$16.88
GF Value R$29.95
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Raia Drogasil ROE % Adjusted to Book Value?

Raia Drogasil BSP:RADL3 +1.08% 91 ROE % Adjusted to Book Value is 1.55% as of Mar. 2026. GuruFocus rates BSP:RADL3 with a GF Score™ of 91/100 and a GF Value™ of R$29.95 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Raia Drogasil's ROE % for the quarter that ended in Mar. 2026 was 8.67%. Raia Drogasil's PB Ratio for the quarter that ended in Mar. 2026 was 5.61. Raia Drogasil's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 1.55%.

Raia Drogasil ROE % Adjusted to Book Value Related Terms

Raia Drogasil ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Raia Drogasil's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raia Drogasil ROE % Adjusted to Book Value Chart

Raia Drogasil Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.94 2.72 2.21 3.31 3.30

Raia Drogasil Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.02 5.86 5.89 2.98 1.55

Raia Drogasil ROE % Adjusted to Book Value Competitor Comparison

For the Pharmaceutical Retailers subindustry, Raia Drogasil's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Raia Drogasil ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's ROE % Adjusted to Book Value falls into.


BSP:RADL3
91GF Score
Raia Drogasil SA BSP:RADL3
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Raia Drogasil ROE % Adjusted to Book Value Calculation

Raia Drogasil's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=18.86% / 5.71
=3.30%

Raia Drogasil's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=8.67% / 5.61
=1.55%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 1.55% mean?
Raia Drogasil (BSP:RADL3) has a ROE % Adjusted to Book Value of 1.55% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Raia Drogasil and its competitors.
Is Raia Drogasil's ROE % Adjusted to Book Value too high?
Raia Drogasil's current ROE % Adjusted to Book Value is 1.55%. Overall, Raia Drogasil has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raia Drogasil's ROE % Adjusted to Book Value compare to competitors?
Raia Drogasil's ROE % Adjusted to Book Value of 1.55% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Raia Drogasil and its competitors. Raia Drogasil's current ROE % Adjusted to Book Value is 1.55%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raia Drogasil stock overvalued right now?
Based on GuruFocus' analysis, Raia Drogasil (BSP:RADL3) is currently considered Significantly Undervalued. The stock's GF Value™ is R$29.95, compared to a current price of R$16.88 — trading 43.6% below its estimated fair value. The current ROE % Adjusted to Book Value is 1.55%. Raia Drogasil's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Raia Drogasil (BSP:RADL3), the current ROE % Adjusted to Book Value is 1.55% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Raia Drogasil (BSP:RADL3) Overvalued in 2026?

Based on GuruFocus' analysis, Raia Drogasil stock appears to be undervalued. The current stock price of R$16.88 is trading 43.6% below its estimated GF Value™ of R$29.95. GuruFocus considers Raia Drogasil to be Significantly Undervalued.

Key valuation signals for BSP:RADL3:

  • ROE % Adjusted to Book Value: 1.55%
  • GF Value™: R$29.95 vs. price of R$16.88 (43.6% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the BSP:RADL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Raia Drogasil Business Description

Other Exchanges RADLY:USA
Address Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-900
Raia Drogasil SA operates a chain of pharmacies in Brazil. The company is mainly engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines. Its pharmacies mainly operate under the Drogasil and Raia brands.
91GF Score

Get the complete analysis for BSP:RADL3

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$16.88
Price
R$29.95
GF Value